Endocannabinoid system involvement in drug addiction, depression and neurotic disorders

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

VRŠKOVÁ Dagmar

Year of publication 2008
Type Article in Periodical
Magazine / Source Scripta medica
MU Faculty or unit

Faculty of Medicine

Citation
Field Neurology, neurosurgery, neurosciences
Keywords Endocannabinoid system;Dependence;Depression;Anxiety;Pharmacokinetics
Description The aim of this paper is to bring to attention recent evidence on the roles of central endocannabinoid system in neuropsychopathological conditions as are drug dependence, depression, anxiety and aggression. Results of pharmacological studies with cannabinoid receptor ligands in rodent behavioural models reported (behavioural sensitization to drugs of abuse: "open field test", "agonistic behaviour", "I.V. drug self-administration"; depression:"bilateral olfactory bulbectomy", "repeated social defeat"; aggressivity and anxiety: "agonistic behaviour") are expected to show in their outcomes a possibility to predict therapeutic pharmacological intervention into the endocannabinoid system activity in the above mentioned neuropsychiatric disorders.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.